Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care

In the dynamic realm of academia, where scientific publications shape the future, it is crucial for stakeholders to explore the forces driving disruptive changes. These include researchers, reviewers, editors, publishers, funding bodies, and, most importantly, readers. In medicine, science should ultimately strive to serve readers. Advancing academic medicine requires the necessary exercise to balance the need for trustworthy science (studies that improve on value for patients, physicians, and healthcare systems) and the ever-changing landscape of academic publishing with existential flexibility. Graphical abstracts, podcasts, and other multimedia formats have experienced a wider diffusion within the scientific community based on a more accessible, ‘cost-effective’ way of disseminating scientific content to busier readers with less protected time to ‘digest’ them. In this setting, social media has emerged as a powerful tool for scientific dissemination, offering researchers an unprecedented reach to diverse stakeholders. However, such a paradigm shift in delivering science requires judicious navigation between time efficiency and credibility [1]. Besides some pros, such an evolution of scientific publishing has raised concerns about the proliferation of predatory journals. Striking a balance between accessibility and quality is imperative to uphold the integrity of academic publishing. The conversation on integrity in scientific publishing should also include the potential threats that can derive from the indiscriminate use of artificial intelligence (AI) [2]. AI is poised to revolutionise the publishing process, from aiding researchers in writing papers to streamlining the demanding, time-consuming peer-review process to enhancing the precision of editorial decision-making [3]. Additionally, AI holds the potential to convert raw data and complex outputs into practical insights. By automating literature reviews and clinical trial searches, clinicians can develop and analyse publications on intricate topics while staying updated on rapidly evolving documents in the field [4]. Funding entities such as research institutes, non-profit associations, academic networks, pharmaceutical companies, etc., could reshape research priorities, influencing policymakers’ and healthcare systems’ agendas. Balancing financial support with research integrity will be crucial to ensure that the progress of scientific publishing will align with the mission of improving the value of healthcare outcomes. Given the close relationship between funding and access to publications (i.e., through open-access publication models), standardised reporting of the potential influence of funding bodies on the study concept, design, and publication process will aid editors, reviewers, and readers in data interpretation for research purposes and clinical practice [7]. The graphical summary of the interplay of discussed factors is represented in Fig. 1. We believe the above-discussed themes related to the evolution of medical scientific publishing might eventually contribute to reshaping the concept of impactful science. Researchers should remember that research aims to improve patient care by leveraging the paradigm of evidence-based medicine. Robust pillars of academic publishing should consistently contribute to this goal. The academic community must remain vigilant over the evolution of scientific publishing, emphasising the importance of shared rigorous methods to evaluate the quality and impact of science and to judge researchers and journals accordingly. These efforts should also promote honest and effective science communication to ensure that findings are accurately delivered to clinicians, researchers, and patients. Defending the essential value of scientific publishing, harmonising the perspective of those who create (authors), evaluate (reviewers), publish (journals/editors), and benefit (clinicians, researchers, patients, healthcare systems) from science, is a common responsibility that the academic community must embrace. Future efforts by the academic community should be focused on initiatives advocating for the authentic value of science, protecting its integrity, and supporting clinician–scientist missions during their academic path [8]. The authors have no conflict of interest.